A team at ETH Zurich developed a new peptide-based organocatalyst that handles macrocycle formation from start to finish.

The CDMO’s Module 1 commercial production facility to be operational by summer 2026 Hyderabad, March 9th 2026: Neuland Laboratories  will open its new commercial peptide facility in the summer of 2026 ...

Advancements in peptide and oligonucleotide synthesis via precision chemistry are transforming therapeutic development by ...

In the rapidly evolving landscape of regenerative medicine, 2026 has marked a turning point in how we approach recovery. We ...

Fortunately, these giant rings are about to become a lot easier to access. Helma Wennemers and her team at ETH Zurich have ...

The peptide craze is spreading from pharmaceuticals, to cosmetics, to online “shadow markets,” raising environmental and ...

Loti Labs Pioneers Quality in GHRP-6 Research Tampa, United States - March 1, 2026 / Loti Labs / Loti Labs, a prominent ...

Loti Labs produces GHRP-6 peptides to research-grade specifications, ensuring they meet the exact composition required for controlled and repeatable experimental outcomes. Each batch is meticulously ...

Neuland Laboratories Ltd. plans to open a commercial‑scale peptide manufacturing facility in summer 2026 at its 17‑acre Bonthapally campus in Hyderabad.

Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...